tradingkey.logo

Gelteq Ltd

GELS

1.690USD

+0.070+4.32%
Market hours ETQuotes delayed by 15 min
16.31MMarket Cap
LossP/E TTM

Gelteq Ltd

1.690

+0.070+4.32%
More Details of Gelteq Ltd Company
Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a highly versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
Company Info
Ticker SymbolGELS
Company nameGelteq Ltd
IPO dateOct 29, 2024
CEOMr. Nathan Jacob Givoni
Number of employees7
Security typeOrdinary Share
Fiscal year-endOct 29
AddressLevel 4
CityMELBOURNE
Stock exchangeNASDAQ Capital Market Consolidated
CountryAustralia
Postal code3205
Phone61390873990
Websitehttps://www.gelteq.com
Ticker SymbolGELS
IPO dateOct 29, 2024
CEOMr. Nathan Jacob Givoni
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Nathan Jacob Givoni
Mr. Nathan Jacob Givoni
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
657.09K
--
Mr. Simon Hayden Szewach
Mr. Simon Hayden Szewach
Executive Chairman of the Board
Executive Chairman of the Board
338.20K
--
The Hon. Philip A. Dalidakis
The Hon. Philip A. Dalidakis
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Prof. David Morton
Prof. David Morton
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Jeffrey W. (Jeff) Olyniec
Mr. Jeffrey W. (Jeff) Olyniec
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Anthony W. Panther
Mr. Anthony W. Panther
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Nathan Jacob Givoni
Mr. Nathan Jacob Givoni
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
657.09K
--
Mr. Simon Hayden Szewach
Mr. Simon Hayden Szewach
Executive Chairman of the Board
Executive Chairman of the Board
338.20K
--
The Hon. Philip A. Dalidakis
The Hon. Philip A. Dalidakis
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Prof. David Morton
Prof. David Morton
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Jeffrey W. (Jeff) Olyniec
Mr. Jeffrey W. (Jeff) Olyniec
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Anthony W. Panther
Mr. Anthony W. Panther
Chief Financial Officer
Chief Financial Officer
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, May 17
Updated: Sat, May 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Markoff (Jeffrey)
25.86%
Golik (David)
10.73%
Givoni (Nathan Jacob)
6.96%
Crestmont Pty Ltd
6.81%
Barabash Family Trust
4.67%
Other
44.97%
Shareholders
Shareholders
Proportion
Markoff (Jeffrey)
25.86%
Golik (David)
10.73%
Givoni (Nathan Jacob)
6.96%
Crestmont Pty Ltd
6.81%
Barabash Family Trust
4.67%
Other
44.97%
Shareholder Types
Shareholders
Proportion
Individual Investor
48.88%
Corporation
11.48%
Research Firm
0.59%
Hedge Fund
0.27%
Investment Advisor
0.25%
Other
38.53%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
15
5.80M
61.47%
+24.19K
2025Q1
15
5.80M
61.47%
+24.19K
2024Q4
13
5.78M
61.21%
+80.95K
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Markoff (Jeffrey)
2.44M
25.86%
--
--
Nov 15, 2024
Golik (David)
1.01M
10.73%
--
--
Nov 15, 2024
Givoni (Nathan Jacob)
657.09K
6.96%
--
--
Nov 15, 2024
Crestmont Pty Ltd
642.32K
6.81%
--
--
Nov 15, 2024
Barabash Family Trust
441.00K
4.67%
--
--
Nov 15, 2024
Szewach (Simon Hayden)
338.20K
3.58%
--
--
Nov 15, 2024
Olyniec (Jeffrey W.)
164.81K
1.75%
--
--
Nov 15, 2024
Wedbush Securities, Inc.
52.25K
0.55%
+1.25K
+2.45%
Mar 31, 2025
UBS Financial Services, Inc.
23.45K
0.25%
+17.25K
+278.35%
Mar 31, 2025
Citadel Advisors LLC
15.16K
0.16%
-8.58K
-36.14%
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI